semaglutide and gallbladder issues Can I File an Ozempic Lawsuit? semaglutide and gallbladder problems semaglutide

When choosing a treatment for weight loss, its important to understand the benefits of each option

Pick an anchor compound

So, don't expect immediate results

GLP-1 therapy is FDA-approved for chronic weight management in people with overweight and obesity, with safety data supporting years of continuous use

Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)

The STEP trials demonstrated that semaglutide produces weight loss averaging 1522% over 68 weeks, while the SURMOUNT trials showed tirzepatide achieves 2022% weight reduction